Stocks and Investing Stocks and Investing
Wed, November 9, 2022
Tue, November 8, 2022

Tiago Fauth Maintained (APLS) at Hold with Decreased Target to $43 on, Nov 8th, 2022


Published on 2024-10-28 00:01:46 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Decreased Target from $45 to $43 on, Nov 8th, 2022.

Tiago has made no other calls on APLS in the last 4 months.



There are 7 other peers that have a rating on APLS. Out of the 7 peers that are also analyzing APLS, 1 agrees with Tiago's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Monday, September 12th, 2022


These are the ratings of the 6 analyists that currently disagree with Tiago


  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $123 on, Tuesday, October 18th, 2022
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Thursday, September 8th, 2022
  • Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $78 on, Thursday, August 18th, 2022
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $102 on, Tuesday, August 9th, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $86 on, Wednesday, July 20th, 2022
  • Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $75 on, Tuesday, July 19th, 2022
Contributing Sources